The biological function of protein kinase C (PKC) depends on its catalytic activity and spatial localization. Its catalytic competence and localization in the resting state are regulated by serine/threonine phosphorylations, ue., "maturation." Upon stimulation of various receptors, PKC is catalytically activated by several activators including diacylglycerol. In addition, PKC often translocates to particular subcellular compartments including the plasma membrane and Golgi complex, and such translation is here referred to as "targeting." In short, the physiological function of PKC is controlled by the three events: maturation, catalytic activation, and targeting. Catalytic activation and targeting contribute to temporal, spatial, and isotype-specific regulation of PKC. This review summarizes the evidence for the role of these three events in the isotypespecific activation of PKC, with particular emphasis on catalytic activation and targeting by lipid mediators.
localization (reviewed in Ref 2).
Together, these studies demonstrate that the isotype-specific physiological function of PKC is regulated by the three events: maturation, catalytic activation, and targeting ( Fig. 1) .
In the following sections, we review the literature supporting a role for maturation, catalytic activation and targeting in the selective activation of the mammalian PKCs.
Maturation
Using PKCpn as a model, Newton et at. have proposed the following pathway for maturation (2) . The earliest translation products are unphosphorylated, cytoskeletallyassociated proteins. The initial step in maturation is phosphorylation of Thr500 in the activation loop by phosphoinositide-dependent kinase 1 (6) . This aligns the active site, which permits subsequent auto-phosphorylation on Thr641 in the turn motif and Ser660 in the hydrophobic motif (7) . The phosphorylation of Thr in the activation loop is essential for maturation, because the T500A mutation of PKCpn does not become phosphorylated and accumulates in the detergent-insoluble fraction (S). However, once the C-tenninal serine and threonine are phosphorylated, the enzyme assumes its mature conformation, and subsequent dephosphorylation of Thr500 does not alter its ability to be activated and/or to translocate. In contrast, dephosphorylation of the Ser/Thr in the turn motif abolishes kinase activity, suggesting that these residues are critical for activation (7) .
These three sites are conserved among the PKC isotypes (Fig. 2) , suggesting that all PKCs mature via a similar pathway. The exceptions are aPKCs and PKC8. The aPKCs have a glutamic acid instead of serine or threonine in the hydrophobic motif In PKC8, Thr505 in the activation loop is not necessary for its catalytic activity, because the negative charge in the activation loop is compensated by Glu500 (9) . Although a different amino acid, the acidic nature of the substitution is consistent with Newton's model of maturation (2) . This series of phosphorylations is required for 497T  500T  500T  514T  505T  566T  512T  538T  410T  4O3T   Turn motif   638T  642T  641T  655T  643S  710T  655T  676S  560T  555T   Hydrophobic motif   657S  661S  660S  674T  662S  729S  674S  695 S  (579E)  (574E) Number shows position of serine / threonine. the catalytic competence and correct intracellular localization of PKCs in the resting state. Therefore, it represents one of the rate-limiting steps for PKC activation.
Catalytic activation
3-1. Phosphatidylserine. Phosphatddylserine (PS) is necessary for catalytic activity of all PKCs. It is thought to bind to either the Cl or C2 domains but the specific binding site has not been identified. The crystal structure of the C2 domain of PKCa in the presence of Ca 2+ and PS reveals that a short chain of PS is coordinated to the C2 domain {10). In contrast, the binding of PS to the C1B domain of PKCpn has also been reported (11) . Additional studies are necessary to determine how PS interacts with each isotype. binding to the cPKC-C2 domain also induces a conformational change (13, 14) . As the C2 domains of PKCa and p have been crystallized (15, 16) , it is likely that these studies are under way.
In addition to its putative role in modulating the conformation of PKC, Ca 2+ also increases the affinity of the enzyme for PS. The Ca 2+ -induced increase in the affinity of PKC-C2 domain for PS was suggested by initial studies using lyposomes (17) , and directly demonstrated by Newton and coworkers (18, 19) . Interestingly, they also suggested that each isotype of cPKCs is differentially regulated by calcium (19) .
3-3. Lipid mediators. 3-3a. Diacylglycerol (DAG) and phorbol ester. DAG and phorbol ester activate the cPKC and nPKCs by binding to the Cl domain (1, 20) . The Cl domain of the cPKC and nPKCs has two cysteine-rich domains (CIA and CIB), each containing -50 amino acids, including six cysteine and two histidine residues arranged in a zinc finger motif The aPKCs lack one of the cysteinerich domains and thus are insensitive to activation by these compounds. The C1B domain of PKCS has been crystallized and shown to contain a phorbol ester-binding pocket (21) .
Two types of DAG appear to be important for the physiological activation of PKC. One is rapidly produced from phosphatidylinositol 4,5-bisphosphate (PIP 2 ) by phospholipase C upon stimulation of G protein-coupled receptors. The other is thought to result from hydrolysis of phosphatidylcholine (PC). This latter DAG production occurs slowly and is more sustained. In addition to the temporal difference, the fatty acid composition of the DAG derived from PC differs from that released from PIP 2 . Interestingly, PKC isotypes are differentially sensitive to the fatty acid composition of DAG (22) . l-Steroyl-2-arachidonoyl-sn-glycerol (SAG) stimulates PKCa and 8 more effectively than do 1-steroyl-2-docosahexaenoyl-s/i-glycerol (SDG) and 1-steroyl-2-eicosapentaenoyl-glycerol (SEG). In contrast, activation of PKCpi by SDG and SEG is higher than that by SAG. Thus, the composition of the DAG and its temporal release may regulate isotype-selective activation.
3-3b. Fatty acid. Fatty acids are known to activate PKC in an isotype-specific manner (4). For example, saturated fatty acids having a carbon chain length of between C13 and C18-activate PKCa, p, 7, and e in vitro (23) ; and this effect is enhanced by the co-presence of DAG (23, 24) . Similarly, unsaturated fatty acids such as arachidonic and oleic acid stimulate PKC7 and e (23, 24) . In contrast, 8PKC is not activated by saturated fatty acids and is inhibited by arachidonic acid (23) .
3-3c Ceramide. Ceramide, which is produced from sphingomyelin by sphingomyelinase, is also a modulator of PKC activity, although its effects are controversial. Bourbon et al. reported that ceramide directly activates PKC? (25) , while Huwiler et al. failed to show direct binding of radiolabeled ceramide to PKC? (26) . Additionally, ceramide at low concentrations activates PKCa (26) , but at higher concentration it inhibits or has no effect on its kinase activity (26, 27) .
3-3d. Other lipids. Cholesterol sulfate (CS) is a unique lipid in epidermal tissue and a metabolite of cholesterol formed during differentiation of squamous epithelium. It has been shown to selectively activate PKCT) (28) . Phosphatidic acid and lysophospholipids such as lysophosphatidylcholine (LPC) also increase PKC activity (4) . LPC enhances the activity of cPKCs but not nPKCs (29) . Other lipids which modify PKC activity include phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 3,4,5-triphosphate. These compounds activate PKCe, T\, and ?, but not PKCa, p, pn, and 7 (30, 31) .
Taken together, these data demonstrate that DAG is not the only lipid with PKC-activating properties. Other lipids exhibit selective effects on different PKC isotypes, thus providing an intriguing mechanism for isotype selective activation.
3-4. Tyrosine phosphorylation.
In addition to activation by lipid mediators, the catalytic activity of PKC can be modulated by tyrosine phosphorylation; PS is not required for this activation. (The details of this activation will be described in Kikkawa's review in this series.) Briefly, Konishi et al. reported that hydrogen peroxide induces tyrosine phosphorylation of PKCa, pi, 8, 7, and ?, resulting in enhanced enzyme activity (32) . In contrast, Denning et al. demonstrated that the enzymatic activity of PKC8 is inhibited by tyrosine phosphorylation (33) . The explanation for this apparent paradox is not clear but may be due to differences in cell type or mode of activation.
Targeting
Kraft et al. (34) reported for the first time that PKC translocates from the soluble fraction to the particulate fraction in response to phorbol 12-myristate 13-acetate (PMA). Subsequent biochemical and immunochemical approaches using isotype-specific antibodies have revealed that physiological stimulation, including that by thyrotropin-releasing hormone, also induces translocation of PKC (35, reviewed in Refs. 5 and 36) and some responses are isotype-specific: a-thrombin and platelet-derived growth factor induce translocation of PKCa, but not PKCe and ?, to the nucleus in IIC9 and Swiss 3T3 cells (37, 38) . More recently, GFP technology has allowed the dynamic movement of PKC to be visualized in living cells and has confirmed a remarkable diversity in PKC targeting as described in this section. These studies indicate the importance of targeting in regulating the physiological and isotype-specific function of PKC.
At least two domains, Cl and C2, are thought to be involved in targeting (I, 2, 14) . It is hypothesized that Ca 2+ -binding to the C2 domain changes its conformation and increases its affinity for PS, resulting in the membrane targeting. In fact, Ca 2+ ionophores induce translocation to the plasma membrane of GFP fusion proteins containing the PKC7-C2 domain or full-length PKC7 (23, 39), or PKCa (40) . In these translocatdons, Ca 2+ mobilization is synchronized with the membrane targeting of the PKCs (13, 40) .
The Cl domain contains phorbol ester-binding sites (20, 21, 47) . This is evident from studies demonstrating that PMA induces irreversible membrane targeting of the GFPtagged Cl domain of PKC7 (42) or full length of PKCa (40) , pn (42), 7 (39, 41) , 8 (43, 44) , or e (45). DAG, which binds to the same site on the enzyme, causes transient translocation of PKC e to the plasma membrane (46) . Irie et al. reported that the C1B domains of the nPKCs have higher affinity for phorbol ester than their CIA domains (47) . In contrast, the CIA and C IB domains of PKC7 have equivalent affinity (47) . Mutation of the C1B domain of PKC8, but not CIA, impairs PMA-induced translocation (48) , while the CIA and C1B domains of PKC7 are equivalent in their ability to translocate to the plasma membrane in response to PMA (41) .
Blumberg and coworkers reported that phorbol ester and related ligands induce targeting of PKCS to different cellular membranes (49) . Like PMA, phorbol 12,13-dioctanate and phorbol 12,13-nonanoate cause irreversible translocation to the plasma membrane. In contrast, two highly lipophilic derivatives, phorbol 12,13-dibutyrate and phorbol 12,13-dihexanoate, result in localization of PKCS to the nuclear membrane and perinuclear region. Interestingly, the former ligands have high tumor-promoting activities, while the latter compounds are less tumorogenic. For example, a strong tumor promoter, 12-deoxyphorbol 13-tetradecanoate, stimulates PKCS concentration at the plasma membrane, while a natural inhibitor of tumor promotion, bryostatin 1, induces the nuclear membrane targeting (44) .
Fatty acids, as well as other mediators, induce isotypespecific translocation. Saturated fatty acids induce translocation of PKCe from the cytoplasm to the plasma membrane, while arachidonic acid translocates ePKC to the Golgi complex (46) . Unlike PKCe, PKC? can be translocated to the nucleus by AA (our unpublished data), but PKCS is insensitive to this fatty acid (50) . More recently, we demonstrated that the C1B domains of PKCS and e are responsible for their distinct sensitivity to AA (45) . Using 8/e chimeras, we have shown that a chimera of PKCS having the C1B domain of PKCe translocates to the Golgi complex in response to AA, but a chimera of PKCe expressing the C1B domain of PKCS does not respond to AA However, the mechanism of the fatty acid-induced targeting is still unknown and the nature of the interaction between AA and the Cl domain of PKCe remains to be elucidated. Lake AA, ceramide also induces isotype-specific targeting. A membrane permeable analogue of ceramide translocates PKCS and e from the cytoplasm to the Golgi complex, but PKCa and ? are insensitive to this treatment (45, 51) . The same analogue activates PKC8 in vivo via tyrosine phosphorylation, but the ceramide-induced targeting to the Golgi complex does not depend on tyrosine phosphorylation (51) .
Binding of ligands on receptors has isotype-specific effects similar to those described above. Carbacol and angiotensin II induce transient translocation to the plasma membrane of a and fill PKC, respectively (40, 42) . Similarly, PKC-y, 8 , and e are targeted to the plasma membrane in response to purinergic stimulation (50) . We also found that EMF-y stimulation, which generates ceramide, causes translocation of PKC8 to the Golgi complex, in a similar way to treatment of cells with the ceramide analogue (51). Additionally, PAF stimulation, which mobilizes AA in addition to DAG production and Ca 2+ increase, localized £PKC to the nucleus (our unpublished data).
Physiologically, targeting PKC to the plasma membrane is necessary for phosphorylation of membrane-associated substrates. This is clearly illustrated by our experiments demonstrating that PMA-induced targeting of PKCS to the plasma membrane results in phosphorylation of MARCKS on the membrane, whereas PKCS activation by hydrogen peroxide, which does not elicit translocation, fails to phosphorylate this substrate (52) . Other experiments revealed that ceramide-induced targeting of PKCS to the Golgi complex resulted in apoptosis (unpublished data), while PMAinduced activation and plasma membrane targeting of PKCS increased the number of cells in G2/M phase (43) . Thus, differential targeting leads to distinct cellular responses (some of which are summarized in Pig. 3).
The diversity in the number and effects of lipid mediators on PKC localization and cellular responses reflect the importance of targeting in the physiological activation and function of the different PKC isotypes. Thus, targeting plays a major role in regulating isotype-specific signal transduction.
Perspective and conclusion
The importance of targeting in isotype-specific activation of PKC has become apparent, but a question regarding the correlation between targeting and catalytic activation remains to be solved: does PKC translocate after it becomes catalyticaly active or is it activated after its translocation? To address this issue, PKC inhibitors and a kinase-negative mutant have been used. PMA induces translocation of PKC7 in the presence of a PKC inhibitor, staurosporine (39) , and the kmase-dead PKC f$II shows translocation, although its re-translocation is inhibited (53) . Moreover, PKC8 can translocate to the Golgi complex without catalytic activation in response to ceramide (51) . These results indicate that translocation of PKC is independent of its catalytic activity. However, we can not conclude that PKC becomes catalytically active after translocation, because hydrogen peroxide activates PKCS without translocation (51) . Development of a fluorescent substrate which will enable us to spatio-temporally visualize PKC phosphorylation would be useful to evaluate the correlation between translocation and catalytic activation.
Although the molecular mechanism of PKC targeting is not well understood, a scaffold protein such as AKAP or RACKS may determine the localization of PKC when activated (reviewed in Refs. 54 and 55). Lipid mediators can be also candidates as targeting modulator.
In conclusion, the physiological function of PKC is regulated by maturation, catalytic activation and targeting. Catalytic activation and targeting are temporally and spatially orchestrated, contributing to isotype-specific activation of PKC under physiological conditions. In these events, lipid mediators play important roles.
